[1]G.Squillace.Rheumatic diseases in the Corpus Hippocraticum[J].Reumatismo, 2007, 59(1): 1-5.
[2]I.J.Hyndman.Rheumatoid arthritis: past, present and future approaches to treating the disease[J].Int J Rheum Dis, 2017, 20(4): 417-419.
[3]D.Bosnic'.The history of systemic lupus erythematosus[J].Reumatizam, 2009, 56(2): 9-15.
[4]H.Armando Laborde, P.Young.History of systemic sclerosis[J].Gaceta medica de Mexico, 2012, 148(2): 201-208.
[5]J.Fellmann.Correct and incorrect paths in the history of ankylosing spondylitis[J].Schweizerische Rundschau fur Medizin Praxis=Revue suisse de medecine Praxis, 1991, 80(21): 576-579.
[6]B.Halioua.A history of psoriasis[J].Annales de dermatologie et de venereologie, 2019, 146(2): 160-165.
[7]H.Keino, A.A.Okada.Behçet's disease: global epidemiology of an Old Silk Road disease[J].The British journal of ophthalmology, 2007, 91(12): 1573-1574.
[8]唐瑛,赵庆,闫颖,等.痹与历节病名考辨[J].中国中医基础医学杂志,2016,22(1):10-11,14.
[9]李满意,娄玉钤.痛风的源流及历史文献复习[J].风湿病与关节炎,2018,7(6):57-62.
[10]陈建春,张世俊,付强,等.历代痛风病名研究[J].亚太传统医药,2021,17(4):171-174.
[11]洪强.红斑狼疮古今中医病名探源[J].中医文献杂志,2008,26(2):13-15.
[12]焦树德.类风湿关节炎从尪痹论治[J].江苏中医药,2008,40(1):5-6.
[13]姜泉,张华东,陈祎,等.路志正治疗干燥综合征经验[J].中医杂志,2016,57(6):463-465.
[14]焦树德从大偻论治强直性脊柱炎三方[J].山东中医杂志,2003,22(4):235.
[15]王承德,沈丕安,胡荫奇.实用中医风湿病学(第2版)[M].北京:人民卫生出版社,2012:434.
[16]OKADA Y, WU D, TRYNKA G, et al.Genetics of rheumatoid arthritis contributes to biology and drug discovery[J].Nature, 2014, 506(7488): 376-381.
[17]BROWN M A.Progress in the genetics of ankylosing spondylitis[J].Briefings in functional genomics, 2011, 10(5): 249-257.
[18]PERRICONE C, CECCARELLI F, SACCUCCI M, et al.Porphyromonas gingivalis and rheumatoid arthritis[J].Current opinion in rheumatology, 2019, 31(5): 517-524.
[19]SANCHEZ-GUERRERO J, KARLSON E W, LIANG M H, et al.Past use of oral contraceptives and the risk of developing systemic lupus erythematosus[J].Arthritis and rheumatism, 1997, 40(5): 804-808.
[20]ROOD M J, VAN DER VELDE E A, TEN CATE R, et al.Female sex hormones at the onset of systemic lupus erythematosus affect survival[J].British journal of rheumatology, 1998, 37(9): 1008-1010.
[21]SOKKA T, TOLOZA S, CUTOLO M, et al.Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study[J].Arthritis research & therapy, 2009, 11(1): R7.
[22]CAPELLINO S, MONTAGNA P, VILLAGGIO B, et al.Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia[J].Clinical and experimental rheumatology, 2008, 26(5): 903-909.
[23]D'ELIA H F, LARSEN A, MATTSSON L A, et al.Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis[J].The Journal of rheumatology, 2003, 30(7): 1456-1463.
[24]ARNSON Y, SHOENFELD Y, AMITAL H.Effects of tobacco smoke on immunity, inflammation and autoimmunity[J].Journal of autoimmunity, 2010, 34(3): J258-265.
[25]KIYOHARA C, WASHIO M, HORIUCHI T, et al.Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population[J].Scandinavian journal of rheumatology, 2012, 41(2): 103-109.
[26]巩勋,崔家康,姜泉,等.1388例类风湿关节炎患者中医证型与疾病活动度特征横断面调查[J].中医杂志,2021,62(4):312-317.
[27]GATEVA V, SANDLING J K, HOM G, et al.A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus[J].Nature genetics, 2009, 41(11): 1228-1233.
[28]范永升.中医药治疗系统性红斑狼疮的探讨[J].浙江中医杂志,2002,37(5):18-19.
[29]FURUKAWA F, ITOH T, WAKITA H, et al.Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity[J].Clinical and experimental immunology, 1999, 118(1): 164-170.
[30]卞华,温成平,范永升.解毒祛瘀滋阴法治疗系统性红斑狼疮的机理浅探[J].中医药学刊,2004,22(9):1715-1716.
[31]李延婷,巩勋,姜泉,等.气象要素对类风湿关节炎中医证候分布的影响[J].中华中医药杂志,2021,36(1):386-389.
[32]胡艳,吴丽红.类风湿性患者的血液流变学指标分析[J].中国热带医学,2007,7(3):359.
[33]张少红.活动期类风湿关节炎痰瘀积分与腕关节积液、滑膜、血流彩超指数的相关性研究[D].福建:福建中医药大学,2017:13-14.
[34]DONG Z, ZHAO D, YANG C, et al.Common Variants in LRP2 and COMT Genes Affect the Susceptibility of Gout in a Chinese Population[J].PloS one, 2015, 10(7): e0131302.
[35]师晓毅.高尿酸血症与中医体质的相关性及复方土茯苓颗粒干预作用的研究[D].广州:广州中医药大学,2015:19.
[36]徐丽萍,李雪梅,魏茂元.系统性硬化症与血液流变学关系的探讨[J].中国血液流变学杂志,2004,14(1):91-92.
[37]吴德鸿,李正富,范永升.范永升教授治疗硬皮病经验[J].中华中医药杂志,2015,30(6):1990-1992.
[38]党晨.调气通痹汤治疗局限性硬皮病的临床观察[D].哈尔滨:黑龙江中医药大学,2017:8.
[39]范永升.系统性红斑狼疮的中医临床探索与实践[J].浙江中医药大学学报,2019,43(10):1030-1035.
[40]吴启富.风湿病中西医结合治疗的必要性探讨[C].//全国第十二届中西医结合风湿病学术会议论文汇编.天津:中国中西医结合学会风湿病专业委员会,2014:3.
[41]范永升.关于争论与中医多元发展[J].中华中医药杂志,2016,31(7):2455-2458.
[42]姜泉,王海隆,巩勋,等.类风湿关节炎病证结合诊疗指南[J].中医杂志,2018,59(20):1794-1800.
[43]孙小燕.浅谈中西药联合应用的利与弊[J].中国中医药现代远程教育,2010,8(2):45.
[44].Fan X X, Xu M Z, Leung L H, et al.ROS-Responsive Berberine Polymeric Micelles Effectively Suppressed the Inflammation of Rheumatoid Arthritis by Targeting Mitochondria[J].Nano-Micro Letters, 2020, 12(1): 1-14.
[45]沈鹰.风湿病中西医诊疗方案探讨[C].//全国第七届中西医结合风湿病学术会议论文汇编.北京:中国中西医结合学会风湿病专业委员会,2008:85-89.
[46]史金花,赵钢.浅谈风湿病饮食疗法[C].//中国首届“十一五”医药发展高峰论坛.拉萨:中国医药导报杂志社,2007:99-100.
[47]FANET-GOGUET M, MARTIN S, FERNANDEZ C, et al.Focus on biological agents in rheumatoid arthritis: newer treatments and therapeutic strategies[J].Therapie, 2004, 59(4): 451-461.
[48]O'DELL J R.Therapeutic strategies for rheumatoid arthritis[J].N Engl J Med, 2004, 350(25): 2591-2602.
[49]GRAVALLESE E M, WALSH N C.Rheumatoid arthritis: Repair of erosion in RA--shifting the balance to formation[J].Nat Rev Rheumatol, 2011, 7(11): 626-628.
[50]CAMERON M, GAGNIER J J, LITTLE C V, et al.Evidence of effectiveness of herbal medicinal products in the treatment of arthritis.Part 2: Rheumatoid arthritis[J].Phytother Res, 2009, 23(12): 1647-1662.
[51]ERNST E, POSADZKI P.Complementary and alternative medicine for rheumatoid arthritis and osteoarthritis: an overview of systematic reviews[J].Curr Pain Headache Rep, 2011, 15(6): 431-437.
[52]吕诚,赵林华,肖诚,等.类风湿关节炎患者外周血CD4 + T淋巴细胞基因表达谱研究探讨[J].中华风湿病学杂志,2006,10(7):438-439.
[53]吕诚,肖诚,赵林华,等.寒热证候类风湿性关节炎患者外周血CD4 + T淋巴细胞基因表达谱初步探索[J].中国中医基础医学杂志,2006,12(2):130-133.
[54]肖诚,吕诚,赵林华,等.活动期和稳定期类风湿性关节炎寒热证候患者外周血CD4 + T淋巴细胞基因表达谱探索[J].中国中医药信息杂志,2006,13(3):14-16.
[55]肖诚,赵林华,吕诚,等.类风湿关节炎类风湿因子阴性和阳性寒热证候患者外周血CD4 + T细胞基因差异表达研究[J].中国中西医结合杂志,2006,26(8):689-693.
[56]查青林,何羿婷,闫小萍,等.类风湿性关节炎主观症状因子分析及其与免疫指标的关系[J].中国中医基础医学杂志,2005,11(11):839-841.
[57]赵林华,肖诚,闫小萍,等.早期类风湿关节炎寒热证候分类与细胞因子及有关临床指标的相关性研究[J].上海中医药大学学报,2006,20(1):21-24.
[58]查青林,何羿婷,喻建平,等.基于决策树分析方法探索类风湿性关节炎证病信息与疗效的相关关系[J].中国中西医结合杂志,2006,26(10):871-876.
[59]王建,巩勋,唐晓颇,等.1602例类风湿关节炎患者中医证候分布特点的多中心横断面调查[J].中医杂志,2018,59(11):963-967.
[60]GONG X, LIU W X, TANG X P, et al.Traditional Chinese Medicine Qingre Huoxue Treatment vs.the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial[J].Front Pharmacol, 2021, 12: 679588.
[61]蒋明.风湿病学[M].北京:科学出版社,1995:1042-1044.
[62]JACOBSON D L, GANGE S J, ROSE N R, et al.Epidemiology and estimated population burden of selected autoimmune diseases in the United States[J].Clin Immunol Immunopathol, 1997, 84(3): 223-243.
[63]乌·乌日娜,苏日古嘎,孙志强.糖皮质激素药物系统应用的副作用及规避对策[J].中国医学文摘(皮肤科学),2015,32(3):248-252.
[64]黄文彦.免疫抑制剂毒副作用及临床使用的相关问题[J].中国当代儿科杂志,2007,9(2):107-112.
[65]温成平,范永升,李永伟,等.中西医结合治疗系统性红斑狼疮的增效减毒作用研究[J].浙江中医药大学学报,2007,31(3):305-309.
[66]温成平,范永升,李夏玉,等.中医解毒祛瘀滋阴法对SLE患者生存质量的影响研究[J].中华中医药学刊,2007,25(8):1599-1602.
[67]范永升,温成平,吴国琳,等.解毒祛瘀滋阴法对系统性红斑狼疮类固醇性骨质疏松症的防治作用研究[J].中华中医药杂志,2005,20(11):667-669.
[68]温成平,范永升,陈学奇,等.解毒祛瘀滋阴药并用激素对系统性红斑狼疮T细胞亚群Fas基因表达的干预作用研究[J].中国中西医结合肾病杂志,2003,4(12):703-705.
[69]温成平,范永升,许志良,等.解毒祛瘀滋阴药与激素对系统性红斑狼疮T细胞亚群Bcl-2基因表达的干预作用研究[J].中国中西医结合肾病杂志,2006,7(5):272-274.
[70]温成平,曹灵勇,王新昌,等.解毒祛瘀滋阴药对SLE患者Bax/Bcl-2基因mRNA表达的影响[J].浙江中西医结合杂志,2007,17(6):333-335.
[71]王新昌,谢志军,孙静,等.中药狼疮定方对MRL/lpr小鼠外周血淋巴细胞凋亡和Bcl-2/Bax基因表达的影响[J].浙江医学,2008,30(11):1187-1190.
[72]曹灵勇,谢志军,王新昌,等.解毒祛瘀滋阴药对MRL/lpr小鼠外周血淋巴细胞凋亡及线粒体跨膜电位的影响[J].中国基层医药,2010,17(6):733-735.
[73]王新昌,曹灵勇,温成平,等.狼疮定颗粒对系统性红斑狼疮患者外周血淋巴细胞凋亡及其[Ca 2+ ]i的影响[J].中医杂志,2007,48(10):898-900.
[74]范永升,温成平,李永伟,等.解毒祛瘀滋阴法治疗SLE对撤减激素和保护下丘脑-垂体-肾上腺轴的作用研究[J].浙江中医药大学学报,2006,30(2):199-202.
[75]温成平,唐晓颇,范永升,等.解毒祛瘀滋阴法配合激素治疗系统性红斑狼疮及其对下丘脑-垂体-肾上腺轴的作用研究[J].北京中医药大学学报,2007,30(7):494-497.
[76]许凤全,冯兴华.强直性脊柱炎中医证候分型研究进展[J].中国中医药信息杂志,2008,15(8):104-5.
[77]许凤全,冯兴华,刘汉卿.治疗强直性脊柱炎常用中药分析[J].中国中医骨伤科杂志,2008,16(11):61-4.
[78]冯兴华,姜泉,刘宏潇,等.中医辨证治疗强直性脊柱炎的临床疗效评价[J].中国中西医结合杂志,2013,33(10):1309-1314.
[79]Huang Run-Yue, Pan Hu-Dan, Wu Jia-Qi, et al.Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial.[J].Phytomedicine, 2019, 57: 403-410.
[80]顾菲,孙玥,陈思文,等.青藤碱联合甲氨蝶呤治疗活动性类风湿关节炎临床研究[J].上海中医药杂志,2014,48(6):58-60.
[81]陈小波,周小斌,李祖建.盐酸青藤碱穴位离子导入治疗膝骨关节炎的临床研究[J].上海针灸杂志,2018,37(1):82-85.
[82]罗慧臣,胡丹慧.盐酸氨基葡萄糖联合青藤碱治疗膝骨关节炎的有效性与安全性[J].中成药,2019,41(3):708-710.
[83]尹耕,谢其冰.盐酸青藤碱缓释片治疗强直性脊柱炎68例临床分析[J].现代预防医学,2009,36(1):184-185,188.
[84]侯新聚,马红梅,朱满华.运用红外热像评价青藤碱定点介入治疗痛风性关节炎的临床疗效观察[J].临床医药实践,2020,29(8):563-566.
[85]张宁,易无庸.昆仙胶囊临床应用进展[J].中医临床研究,2014,6(7):147-148.
[86]刘艳梅,雷易萌,张贝,等.昆仙胶囊治疗类风湿关节炎的临床研究[J].解剖科学进展,2019,25(1):17-20.
[87]林昌松,杨岫岩,戴冽,等.昆仙胶囊治疗类风湿关节炎多中心临床研究[J].中国中西医结合杂志,2011,31(6):769-774.
[88]高明利,李晓晨,齐庆.昆仙胶囊降低狼疮性肾炎尿蛋白的临床观察[J].中药材,2010,33(4):651-652.
[89]项协隆,邵思思,黄蔚霞.昆仙胶囊治疗狼疮肾炎伴肾病综合征表现患者的肾功能及血清IgE IgG水平改善研究[J].中国药物与临床,2019,19(5):710-713.
[90]林昌松,刘明岭,徐强,等.昆仙胶囊治疗强直性脊柱炎疗效观察[J].新医学,2011,42(3):175-178.
[91]秦万章.雷公藤制剂治疗60例系统性红斑狼疮总结[J].中成药研究,1982,4(9):25-27.
[92]吴文媛,金岚,秦万章.雷公藤糖浆治疗190例银屑病的临床观察及其机理探讨[J].中国皮肤性病学杂志,1991,4(1):27-28.
[93]张鸣鹤.清热解毒法治疗自身免疫性疾病的新思路[C].//第六届中国中西医结合风湿病学术会议论文汇编.浙江:中国中西医结合学会风湿类疾病专业委员会,2006:56-58.
[94]付新利,张立亭,吴霞.张鸣鹤诊治风湿性疾病经验[J].山东中医杂志,2008,27(10):709-711.
[95]房定亚,张颖,杨怡坤,等.房定亚风湿病专方专药要略[M].北京:北京科学技术出版社,2016:22-45.
[96]De Camargo M C, Barros B C A, Fulone I, et al.Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting[J].Front Pharmacol, 2019(10): 965.
[97]菅向东,宁琼.关注风湿性疾病治疗中生物制剂的不良反应[J].新医学,2009,40(5):281-284.
[98]Lin X, Shao T, Huang L, et al.Simiao Decoction Alleviates Gouty Arthritis by Modulating Proinflammatory Cytokines and the Gut Ecosystem[J].Front Pharmacol, 2020, 11: 955.
[99]Yang J, Chen G, Guo TW, et al.Simiao Wan attenuates monosodium urate crystal-induced arthritis in rats through contributing to macrophage M2 polarization[J].J Ethnopharmacol, 2021, 15(275): 114-123.